Skip to main content
PACS
NYSE Industrial Applications And Services

Officer and Director Mark Hancock files Form 144 to sell $2.5M in stock, following $16.3M in recent sales

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$41.178
Mkt Cap
$6.517B
52W Low
$7.5
52W High
$43.08
52W Position info
449% above low
Off High info
4.4% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

PACS has more than doubled off its 52-week low of $7.5.

Summary

Mark Hancock, an Officer and Director at PACS Group, filed a Form 144 indicating intent to sell $2.5 million in common stock, adding to over $16 million in sales by him in the past three months.


Key Events · Ownership and Investor Activity · PACS

  • Proposed Stock Sale

    Mark Hancock, an Officer, Director, and 10% Stockholder, filed a Form 144 to sell 61,931 shares of common stock, valued at approximately $2.51 million.

  • Significant Recent Selling Activity

    This filing also discloses that Mark Hancock has sold 438,069 shares for gross proceeds of $16.37 million over the past three months, indicating a pattern of ongoing insider sales.

  • Selling Near 52-Week Highs

    The proposed sale and recent selling activity occur while PACS Group's stock is trading near its 52-week high, suggesting the insider is capitalizing on favorable market conditions.

  • Part of Ongoing Insider Distribution

    This is the latest in a series of Form 144 filings from PACS Group insiders, contributing to a net distribution of over $13.8 million in insider sales over the last 90 days.


Analysis · PACS · Industrial Applications And Services

This Form 144 indicates that Mark Hancock, a key insider serving as an Officer, Director, and 10% Stockholder, intends to sell an additional $2.5 million in company stock. This proposed sale is significant when viewed in the context of his recent activity, as the filing also discloses he has already sold over $16 million in PACS Group stock in the past three months. This ongoing selling by a top executive, especially while the stock is trading near its 52-week high, suggests profit-taking and adds to a broader pattern of insider distribution, which could be perceived negatively by investors.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PACS was trading at $41.18 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6.5B. The 52-week trading range was $7.50 to $43.08. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PACS - Latest Insights

PACS
Nov 03, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $46.68
Real-time Price: $46.57 info
Change: -$0.110 (-0.24%) info
Market Cap: $7.349B info
PACS
Nov 03, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $46.68
Real-time Price: $46.57 info
Change: -$0.110 (-0.24%) info
Market Cap: $7.349B info
PACS
Nov 03, 2026, 4:15 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $46.68
Real-time Price: $46.57 info
Change: -$0.110 (-0.24%) info
Market Cap: $7.349B info
PACS
Sep 21, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $42.06
Real-time Price: $46.57 info
Change: +$4.51 (+11%) info
Market Cap: $7.349B info
PACS
Sep 01, 2026, 4:16 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $42.14
Real-time Price: $46.57 info
Change: +$4.43 (+11%) info
Market Cap: $7.349B info